Farallon Capital Management: 13F holdings, Q2 2026
Emerging, concentrated · SEC EDGAR filings (CIK 0000909661) · Explore on the interactive board
Farallon Capital Management disclosed 86 US equity positions worth $17.1bn in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is RVMD at 14.9% of the reported book, followed by EA, BBIO. The top ten holdings are 55.7% of the book, and the portfolio behaves like about 19 equal-weight positions. Versus the prior filing it opened 20 new positions, added to 29, reduced 22 and exited 25.
$17.1bnreported US equity book
86positions
14.9%largest position
55.7%top 10 weight
19.27effective positions (1/HHI)
113quarters on file since Q1 1998
What does Farallon Capital Management own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 20 new, 29 added, 22 reduced, 25 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | RVMD REVOLUTION MEDICINES INC | Healthcare | 14.9% | $2.5bn | 13,550,796 | -0% | held |
| 2 | EA ELECTRONIC ARTS INC | Communication Services | 9.5% | $1.6bn | 7,919,500 | 6% | added |
| 3 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 4.7% | $800.1m | 10,743,063 | 15% | added |
| 4 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 4.6% | $778.2m | 6,348,906 | 0% | held |
| 5 | EXEL EXELIXIS INC | Healthcare | 4.3% | $732.8m | 13,468,010 | 3% | added |
| 6 | LQDA LIQUIDIA CORPORATION | Healthcare | 3.9% | $666.9m | 8,365,038 | -3% | reduced |
| 7 | AMZN AMAZON COM INC | Consumer Cyclical | 3.7% | $627.5m | 2,632,994 | -38% | reduced |
| 8 | LNTH LANTHEUS HLDGS INC | Healthcare | 3.6% | $619.4m | 5,583,479 | 0% | held |
| 9 | NTRA NATERA INC | Healthcare | 3.5% | $602.2m | 2,218,366 | -31% | reduced |
| 10 | UNH UNITEDHEALTH GROUP INC | Healthcare | 3.1% | $528.1m | 1,270,532 | -30% | reduced |
| 11 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 3.1% | $526.0m | 1,049,185 | 19% | added |
| 12 | ROIV ROIVANT SCIENCES LTD | Healthcare | 3.0% | $506.4m | 14,309,000 | 48% | added |
| 13 | AON AON PLC | Financial Services | 2.7% | $458.6m | 1,382,562 | -45% | reduced |
| 14 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 2.6% | $449.0m | 10,521,184 | 41% | added |
| 15 | AVGO BROADCOM INC | Technology | 2.5% | $435.1m | 1,151,800 | -35% | reduced |
| 16 | MSFT MICROSOFT CORP | Technology | 2.4% | $415.1m | 1,112,863 | -53% | reduced |
| 17 | TNGX TANGO THERAPEUTICS INC | Healthcare | 2.2% | $383.8m | 12,277,000 | 35% | added |
| 18 | KKR KKR & CO INC | Financial Services | 2.2% | $378.0m | 4,118,300 | -12% | reduced |
| 19 | SNPS SYNOPSYS INC | Technology | 2.2% | $370.1m | 829,600 | -32% | reduced |
| 20 | BEAM BEAM THERAPEUTICS INC | Healthcare | 2.1% | $351.3m | 10,236,396 | 1% | added |
| 21 | CRINETICS PHARMACEUTICALS IN | 2.0% | $336.4m | 8,989,098 | 8% | added | |
| 22 | GRAL GRAIL INC | 1.7% | $284.1m | 4,161,584 | 28% | added | |
| 23 | WAB WABTEC | Industrials | 1.4% | $241.2m | 894,503 | -44% | reduced |
| 24 | IMVT IMMUNOVANT INC | Healthcare | 1.3% | $223.7m | 5,805,000 | 275% | added |
| 25 | TWST TWIST BIOSCIENCE CORP | Healthcare | 1.3% | $219.8m | 2,136,400 | 50% | added |
| 26 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.3% | $219.6m | 5,917,400 | 4% | added |
| 27 | ARMK ARAMARK | Industrials | 1.2% | $206.3m | 3,625,731 | -41% | reduced |
| 28 | BIDU BAIDU INC | Communication Services | 0.8% | $137.6m | 1,203,785 | 171% | added |
| 29 | NVO NOVO-NORDISK A S | Healthcare | 0.7% | $125.6m | 2,619,000 | 235% | added |
| 30 | ACHC ACADIA HEALTHCARE COMPANY IN | Healthcare | 0.7% | $124.6m | 4,220,800 | 143% | added |
| 31 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 0.7% | $120.8m | 1,732,800 | 7% | added |
| 32 | AZN ASTRAZENECA PLC | 0.6% | $108.8m | 574,000 | 153% | added | |
| 33 | JNJ JOHNSON & JOHNSON | Healthcare | 0.6% | $103.6m | 408,000 | 176% | added |
| 34 | STRATEGY INC | 0.4% | $75.4m | 87,858,000 | 122% | added | |
| 35 | PARABILIS MEDICINES INC | 0.4% | $64.8m | 2,368,200 | – | new | |
| 36 | NVS NOVARTIS AG | Healthcare | 0.3% | $56.9m | 363,000 | – | new |
| 37 | GH GUARDANT HEALTH INC | Healthcare | 0.3% | $48.3m | 322,200 | 3928% | added |
| 38 | VNET GROUP INC | 0.3% | $46.8m | 45,000,000 | 0% | held | |
| 39 | AVTX AVALO THERAPEUTICS INC | Healthcare | 0.3% | $46.2m | 2,498,000 | 173% | added |
| 40 | JOYY JOYY INC | Communication Services | 0.3% | $46.1m | 699,200 | 21% | added |
| 41 | ASMB ASSEMBLY BIOSCIENCES INC | Healthcare | 0.3% | $44.1m | 1,604,590 | 31% | added |
| 42 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.2% | $35.3m | 2,418,202 | -16% | reduced |
| 43 | MAZE MAZE THERAPEUTICS INC | 0.2% | $33.1m | 1,107,814 | 197% | added | |
| 44 | MRK MERCK & CO INC | Healthcare | 0.1% | $25.6m | 199,000 | -45% | reduced |
| 45 | WRBY WARBY PARKER INC | Healthcare | 0.1% | $25.1m | 828,000 | – | new |
| 46 | PERCEPTIVE CAP SOLUTIONS COR | 0.1% | $24.5m | 2,250,000 | 0% | held | |
| 47 | KAILERA THERAPEUTICS INC | 0.1% | $24.2m | 1,100,000 | – | new | |
| 48 | RIO RIO TINTO PLC | Basic Materials | 0.1% | $17.4m | 183,475 | 241% | added |
| 49 | AXALTA COATING SYS LTD | 0.1% | $16.4m | 478,000 | – | new | |
| 50 | ABVX ABIVAX SA | 0.1% | $16.3m | 122,000 | 6000% | added |
What did Farallon Capital Management sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| SCHW SCHWAB CHARLES CORP | 15.4% | $371.8m |
| GOOG ALPHABET INC | 11.8% | $285.8m |
| V VISA INC | 10.5% | $254.1m |
| DIS DISNEY WALT CO | 9.6% | $231.5m |
| MA MASTERCARD INCORPORATED | 9.0% | $217.4m |
| MCK MCKESSON CORP | 8.4% | $202.8m |
| CNTA CENTESSA PHARMACEUTICALS PLC | 7.9% | $191.0m |
| TYRA TYRA BIOSCIENCES INC | 5.7% | $137.1m |
| THC TENET HEALTHCARE CORP | 3.5% | $85.3m |
| CAH CARDINAL HEALTH INC | 3.2% | $77.8m |
| PCVX VAXCYTE INC | 3.0% | $73.3m |
| DNTH DIANTHUS THERAPEUTICS INC | 2.9% | $70.2m |
| BITWISE 10 CRYPTO INDEX ETF | 1.1% | $26.9m |
| RPRX ROYALTY PHARMA PLC | 1.0% | $23.6m |
| CECO CECO ENVIRONMENTAL CORP | 0.6% | $13.9m |
| GDS GDS HLDGS LTD | 0.5% | $11.8m |
| FORM FORMFACTOR INC | 0.2% | $5.5m |
| MTZ MASTEC INC | 0.2% | $5.5m |
| ENTG ENTEGRIS INC | 0.2% | $5.3m |
| C CITIGROUP INC | 0.2% | $5.3m |
| H HYATT HOTELS CORP | 0.2% | $5.2m |
| WAL WESTERN ALLIANCE BANCORP | 0.2% | $5.2m |
| TKR TIMKEN CO | 0.2% | $5.1m |
| FLEX FLEXTRONICS INTL LTD | 0.2% | $5.1m |
| SPGI S&P GLOBAL INC | 0.2% | $5.1m |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 64.1% |
| Communication Services | 10.7% |
| Technology | 7.2% |
| Financial Services | 4.9% |
| Consumer Cyclical | 3.7% |
| Industrials | 2.6% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
| Quarter | Positions | Equity value |
|---|---|---|
| Q2 2026 | 86 | $17.1bn |
| Q1 2026 | 170 | $16.9bn |
| Q4 2025 | 148 | $19.2bn |
| Q3 2025 | 139 | $17.7bn |
| Q2 2025 | 143 | $21.9bn |
| Q1 2025 | 144 | $18.5bn |
| Q4 2024 | 146 | $19.0bn |
| Q3 2024 | 160 | $18.2bn |
| Q2 2024 | 162 | $16.9bn |
| Q1 2024 | 172 | $17.0bn |
| Q4 2023 | 157 | $16.0bn |
| Q3 2023 | 163 | $17.7bn |
| Q2 2023 | 171 | $16.7bn |
| Q1 2023 | 192 | $16.5bn |
| Q4 2022 | 242 | $15.5bn |
| Q3 2022 | 309 | $1.4tn |
Earliest filing: Q1 1998 · 113 quarters on file
How concentrated is Farallon Capital Management's portfolio?
Across every quarter Farallon Capital Management has filed, its median largest position is 11.1% of the book and its median top-ten weight is 49.3%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 3328 completed holding spells, the median lasted 2.0 quarters; 86 positions are still open and their final length is unknown.